VRCI vs. ABDX, PRM, GDR, GENI, DMTR, LLAI, LLA, IDHC, DXRX, and AGL
Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Abingdon Health (ABDX), Proteome Sciences (PRM), genedrive (GDR), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), Diaceutics (DXRX), and ANGLE (AGL). These companies are all part of the "diagnostics & research" industry.
Verici Dx vs.
Verici Dx (LON:VRCI) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk, community ranking and dividends.
51.9% of Verici Dx shares are held by institutional investors. Comparatively, 33.5% of Abingdon Health shares are held by institutional investors. 17.1% of Verici Dx shares are held by insiders. Comparatively, 48.9% of Abingdon Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Verici Dx has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500. Comparatively, Abingdon Health has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500.
Abingdon Health has lower revenue, but higher earnings than Verici Dx. Abingdon Health is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.
Verici Dx and Abingdon Health both received 0 outperform votes by MarketBeat users.
Abingdon Health has a net margin of -20.72% compared to Verici Dx's net margin of -110.99%. Abingdon Health's return on equity of -62.56% beat Verici Dx's return on equity.
In the previous week, Verici Dx's average media sentiment score of 0.00 equaled Abingdon Health'saverage media sentiment score.
Summary
Abingdon Health beats Verici Dx on 7 of the 11 factors compared between the two stocks.
Get Verici Dx News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart
Verici Dx Competitors List
Related Companies and Tools
This page (LON:VRCI) was last updated on 5/22/2025 by MarketBeat.com Staff